ALKERMES | ALKS - Credores Comerciais





Credores Comerciais Alterar Data
AbbVie USD 3.59B 28.65B 2025-12
Acadia Pharmaceuticals USD 12.25M 1.34M 2026-03
ALKERMES USD 102.36M 5.59M 2026-03
Amgen USD 19.52B 1.37B 2026-03
Biogen USD 358.5M 73.5M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Coherus Biosciences USD 9.91M 14.98M 2025-12
Eli Lilly USD 5.03B 350M 2026-03
Gilead Sciences USD 645M 70M 2026-03
Heron Therapeutics USD 8.97M 24K 2026-03
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
J&J USD 10.46B 1.53B 2026-03
Malin Corporation EUR 700K 200K 2024-12
Merck USD 3.86B 541M 2026-03
Minerva Neurosciences USD 640K 305K 2025-12
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Otsuka Holdings JPY 196.04B 29.53B 2026-03
Ovoca Bio EUR 186K 23K 2025-06
Pfizer USD 4.51B 734M 2026-03
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03